News | December 14, 2021
Baxter acquires Hillrom for US $ 15 billion
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities
Results from the ongoing vodobatinib clinical study are being presented for the second consecutive year at the ASH annual meeting, underlining the promising potential of the drug for the treatment of heavily pre-treated CML
The company will donate 5000 nebulizers to primary health care centres in rural India
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19
Approximately five kg tumor was removed in the eight-hour long complicated surgery
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Subscribe To Our Newsletter & Stay Updated
